Producción de forraje verde hidropónico de cebada (Hordeum vulgare) usando efluente de piscigranja de truchas

The objective was to determine the effect of trout farm effluent on the production of green hydroponic forage of barley (GHF). The activities were: oxidation of ammonia (N-NH4+) in the trout farm effluent to nitrate of nitrogen (N-NO3-) in a biofilter (nitrification), and the use of this effluent in the production of GHF. Design was completely randomized with three treatments: 100% of water from water supply channel (T0), 50% of water from biofilter effluent, plus 50% of water from water supply channel (T1), and 100% of water from biofilter effluent (T2); with 10 replications. Variables assessed were: development time of biofilter; NNO3- content in fully developed biofilter; percentage of protein and plant height on 4th, 8th, 12th, and 16th day production; and biomass production of GHF on 16th day. By the end of the 90th day, the biofilter installed to generate N-NO3- was developed at a medium pH of 8.23 and at a medium temperature of 14.9°C. N-NO3- content (mg/L) in biofilter effluent was 2.2 while trout farm effluent was 1.2. No significant difference was found in protein percentage of GHF (P<0.05). However, there was a highly significant effect (P<0.01) on plant height the 4th, 8th, 12th, and 16th days, and biomass production on the 16th day. For both variables, treatment T2 was placed in the A range, treatment T1 in B range and treatment T0 in C range.El objetivo fue determinar el efecto del efluente de pozas de trucha sobre la producción de forraje verde hidropónico de cebada (FVH). Las actividades fueron: La oxidación del amoniaco (N-NH4+) – en el efluente de las pozas de trucha – hasta nitrato (N-NO3-) en un biofiltro (nitrificación) y el uso del efluente en la producción de FVH. Se utilizó el diseño completamente al azar con tres tratamientos: 100% de agua del canal de abastecimiento (T0), 50% de efluente del biofiltro más 50% de agua del canal de abastecimiento (T1) y 100% de efluente del biofiltro (T2); con 10 repeticiones. Las variables evaluadas fueron: tiempo de desarrollo del biofiltro, contenido de N-NO3- en el biofiltro completamente desarrollado, porcentaje de proteína y altura de planta los días 4, 8, 12 y 16 de producción; y producción de biomasa del FVH el día 16. El biofiltro instalado para la generación de N-NO3- se desarrolló a los 90 días, a un pH medio de 8.23 y una temperatura media de 14.9 °C. El contenido de NNO3-(mg/L) en el efluente del biofiltro fue de 2.2 y en el de las pozas de trucha, 1.2. No se encontraron diferencias significativas (P<0.05) en porcentaje de proteína del FVH, pero se observó un efecto altamente significativo (P<0.01) en la altura de planta los días 4, 8, 12 y 16, asimismo en la producción de biomasa del día 16. Para ambas variables el tratamiento T2 se ubicó en el rango A, el tratamiento T1 en el rango B y el tratamiento T0 en el rango C

Thrombolytic removal of intraventricular haemorrhage in treatment of severe stroke: results of the randomised, multicentre, multiregion, placebo-controlled CLEAR III trial

Background: Intraventricular haemorrhage is a subtype of intracerebral haemorrhage, with 50% mortality and serious disability for survivors. We aimed to test whether attempting to remove intraventricular haemorrhage with alteplase versus saline irrigation improved functional outcome. Methods: In this randomised, double-blinded, placebo-controlled, multiregional trial (CLEAR III), participants with a routinely placed extraventricular drain, in the intensive care unit with stable, non-traumatic intracerebral haemorrhage volume less than 30 mL, intraventricular haemorrhage obstructing the 3rd or 4th ventricles, and no underlying pathology were adaptively randomly assigned (1:1), via a web-based system to receive up to 12 doses, 8 h apart of 1 mg of alteplase or 0·9% saline via the extraventricular drain. The treating physician, clinical research staff, and participants were masked to treatment assignment. CT scans were obtained every 24 h throughout dosing. The primary efficacy outcome was good functional outcome, defined as a modified Rankin Scale score (mRS) of 3 or less at 180 days per central adjudication by blinded evaluators. This study is registered with ClinicalTrials.gov, NCT00784134. Findings: Between Sept 18, 2009, and Jan 13, 2015, 500 patients were randomised: 249 to the alteplase group and 251 to the saline group. 180-day follow-up data were available for analysis from 246 of 249 participants in the alteplase group and 245 of 251 participants in the placebo group. The primary efficacy outcome was similar in each group (good outcome in alteplase group 48% vs saline 45%; risk ratio [RR] 1·06 [95% CI 0·88–1·28; p=0·554]). A difference of 3·5% (RR 1·08 [95% CI 0·90–1·29], p=0·420) was found after adjustment for intraventricular haemorrhage size and thalamic intracerebral haemorrhage. At 180 days, the treatment group had lower case fatality (46 [18%] vs saline 73 [29%], hazard ratio 0·60 [95% CI 0·41–0·86], p=0·006), but a greater proportion with mRS 5 (42 [17%] vs 21 [9%]; RR 1·99 [95% CI 1·22–3·26], p=0·007). Ventriculitis (17 [7%] alteplase vs 31 [12%] saline; RR 0·55 [95% CI 0·31–0·97], p=0·048) and serious adverse events (114 [46%] alteplase vs 151 [60%] saline; RR 0·76 [95% CI 0·64–0·90], p=0·002) were less frequent with alteplase treatment. Symptomatic bleeding (six [2%] in the alteplase group vs five [2%] in the saline group; RR 1·21 [95% CI 0·37–3·91], p=0·771) was similar. Interpretation: In patients with intraventricular haemorrhage and a routine extraventricular drain, irrigation with alteplase did not substantially improve functional outcomes at the mRS 3 cutoff compared with irrigation with saline. Protocol-based use of alteplase with extraventricular drain seems safe. Future investigation is needed to determine whether a greater frequency of complete intraventricular haemorrhage removal via alteplase produces gains in functional status

Características del uso de tratamiento alternativo y complementario en dismenorrea en mujeres en edad fértil

Objetive: To describe the characteristics of the use of alternative and complementary treatment in dysmenorrhea in women of childbearing age in a city in northern Peru. The study: Cross-sectional analytical study in women of childbearing age in Mórrope, Lambayeque. Prior training on dysmenorrhea and main variables. 336 women were interviewed in their homes after accepting informed consent. Findings: The age group of 15 to 35 years prevailed in the studied population with 83.92% (n=282), with secondary education 57.14% (n=192), more than 90% had lower/marginal socioeconomic status. Regarding dysmenorrhea, more than 30% were found to have severe/unbearable pain, whose main treatment was MAC with 82.1% (n=220). Plants were the main MAC, only finding an association of MAC use with the religion variable (p=0.023). Conclusions: Women of childbearing age notoriously use CAM, such as phytotherapy, as a treatment for dysmenorrhea despite not finding reliefObjetivo: Describir las características del uso de tratamiento alternativo y complementario en dismenorrea en mujeres en edad fértil de una ciudad del norte de Perú. El estudio: Estudio trasversal analítico en mujeres en edad fértil en Mórrope, Lambayeque. Previa capacitación sobre dismenorrea y principales variables. Se entrevistó a 336 mujeres en sus domicilios previa aceptación de consentimiento informado. Hallazgos: Predominó en población estudiada el grupo etario de 15 a 35 años con 83,92% (n=282), con educación secundaria el 57,14% (n=192), más del 90% tenían estrato socioeconómico inferior/marginal. Referente a la dismenorrea, se encontró más del 30% con dolor severo/insoportable, cuyo tratamiento principal fue la MAC con 82,1%(n=220). Las plantas fueron la principal MAC, hallando solamente asociación de uso de MAC con la variable religión (p=0,023). Conclusiones: Las mujeres en edad fértil emplean notoriamente la MAC, como la fitoterapia, como tratamiento de dismenorrea a pesar de no encuentran alivio

Minimally invasive stereotactic puncture and thrombolysis therapy improves long-term outcome after acute intracerebral hemorrhage

The purpose of this study was to judge the clinical value of minimally invasive stereotactic puncture and thrombolysis therapy (MISPTT) for acute intracerebral hemorrhage (ICH). A randomized control clinical trial was undertaken. According to the enrollment criteria, 122 acute ICH cases were analyzed, of which 64 cases received MISPTT (MISPTT group, MG) and 58 cases received conventional craniotomy (CC group, CG). The Glasgow coma scale (GCS) scores, postoperative complications (PC), and rebleeding incidences were compared. Moreover, 1 year postoperation, the long-term outcomes of patients with regard to hematoma volume (HV) <50 mL and HV ≥50 mL were judged, respectively, by the Glasgow outcome scale (GOS), Barthel index (BI), modified Rankin Scale (mRS), and case fatality (CF). MG patients showed obvious amelioration in GCS score compared with that of CG patients. The total incidence of PC in MG decreased compared with that of CG. The incidences of rebleeding in MG and CG were 9.4 and 17.2%, respectively (P = 0.243). There were no obvious differences between the CFs of MG and CG (17.2 and 25.9%, respectively, P = 0.199). The GOS, BI, and mRS representing long-term outcome for both HV <50 mL and HV ≥50 mL in MG were ameliorated significantly greater than that in CG patients (all P < 0.05). These data suggest that there are advantages with MISPTT not only in trauma and safety, but the MISPTT group had fewer complications and a trend toward improved short-term and long-term outcomes

Efficacy and safety of minimally invasive surgery with thrombolysis in intracerebral haemorrhage evacuation (MISTIE III): a randomised, controlled, open-label, blinded endpoint phase 3 trial

Acute stroke due to supratentorial intracerebral haemorrhage is associated with high morbidity and mortality. Open craniotomy haematoma evacuation has not been found to have any benefit in large randomised trials. We assessed whether minimally invasive catheter evacuation followed by thrombolysis (MISTIE), with the aim of decreasing clot size to 15 mL or less, would improve functional outcome in patients with intracerebral haemorrhage. MISTIE III was an open-label, blinded endpoint, phase 3 trial done at 78 hospitals in the USA, Canada, Europe, Australia, and Asia. We enrolled patients aged 18 years or older with spontaneous, non-traumatic, supratentorial intracerebral haemorrhage of 30 mL or more. We used a computer-generated number sequence with a block size of four or six to centrally randomise patients to image-guided MISTIE treatment (1·0 mg alteplase every 8 h for up to nine doses) or standard medical care. Primary outcome was good functional outcome, defined as the proportion of patients who achieved a modified Rankin Scale (mRS) score of 0-3 at 365 days, adjusted for group differences in prespecified baseline covariates (stability intracerebral haemorrhage size, age, Glasgow Coma Scale, stability intraventricular haemorrhage size, and clot location). Analysis of the primary efficacy outcome was done in the modified intention-to-treat (mITT) population, which included all eligible, randomly assigned patients who were exposed to treatment. All randomly assigned patients were included in the safety analysis. This study is registered with ClinicalTrials.gov, number NCT01827046. Between Dec 30, 2013, and Aug 15, 2017, 506 patients were randomly allocated: 255 (50%) to the MISTIE group and 251 (50%) to standard medical care. 499 patients (n=250 in the MISTIE group; n=249 in the standard medical care group) received treatment and were included in the mITT analysis set. The mITT primary adjusted efficacy analysis estimated that 45% of patients in the MISTIE group and 41% patients in the standard medical care group had achieved an mRS score of 0-3 at 365 days (adjusted risk difference 4% [95% CI -4 to 12]; p=0·33). Sensitivity analyses of 365-day mRS using generalised ordered logistic regression models adjusted for baseline variables showed that the estimated odds ratios comparing MISTIE with standard medical care for mRS scores higher than 5 versus 5 or less, higher than 4 versus 4 or less, higher than 3 versus 3 or less, and higher than 2 versus 2 or less were 0·60 (p=0·03), 0·84 (p=0·42), 0·87 (p=0·49), and 0·82 (p=0·44), respectively. At 7 days, two (1%) of 255 patients in the MISTIE group and ten (4%) of 251 patients in the standard medical care group had died (p=0·02) and at 30 days, 24 (9%) patients in the MISTIE group and 37 (15%) patients in the standard medical care group had died (p=0·07). The number of patients with symptomatic bleeding and brain bacterial infections was similar between the MISTIE and standard medical care groups (six [2%] of 255 patients vs three [1%] of 251 patients; p=0·33 for symptomatic bleeding; two [1%] of 255 patients vs 0 [0%] of 251 patients; p=0·16 for brain bacterial infections). At 30 days, 76 (30%) of 255 patients in the MISTIE group and 84 (33%) of 251 patients in the standard medical care group had one or more serious adverse event, and the difference in number of serious adverse events between the groups was statistically significant (p=0·012). For moderate to large intracerebral haemorrhage, MISTIE did not improve the proportion of patients who achieved a good response 365 days after intracerebral haemorrhage. The procedure was safely adopted by our sample of surgeons. National Institute of Neurological Disorders and Stroke and Genentech. [Abstract copyright: Copyright © 2019 Elsevier Ltd. All rights reserved.

Elevated intracranial pressure and cerebral edema following permanent MCA occlusion in an ovine model

INTRODUCTION: Malignant middle cerebral artery (MCA) stroke has a disproportionately high mortality due to the rapid development of refractory space-occupying cerebral edema. Animal models are essential in developing successful anti-edema therapies; however to date poor clinical translation has been associated with the predominately used rodent models. As such, large animal gyrencephalic models of stroke are urgently needed. The aim of the study was to characterize the intracranial pressure (ICP) response to MCA occlusion in our recently developed ovine stroke model. MATERIALS AND METHODS: 30 adult female Merino sheep (n = 8-12/gp) were randomized to sham surgery, temporary or permanent proximal MCA occlusion. ICP and brain tissue oxygen were monitored for 24 hours under general anesthesia. MRI, infarct volume with triphenyltetrazolium chloride (TTC) staining and histology were performed. RESULTS: No increase in ICP, radiological evidence of ischemia within the MCA territory but without space-occupying edema, and TTC infarct volumes of 7.9+/-5.1% were seen with temporary MCAO. Permanent MCAO resulted in significantly elevated ICP, accompanied by 30% mortality, radiological evidence of space-occupying cerebral edema and TTC infarct volumes of 27.4+/-6.4%. CONCLUSIONS: Permanent proximal MCAO in the sheep results in space-occupying cerebral edema, raised ICP and mortality similar to human malignant MCA stroke. This animal model may prove useful for pre-clinical testing of anti-edema therapies that have shown promise in rodent studies.Adam J. Wells, Robert Vink, Stephen C. Helps, Steven J. Knox, Peter C. Blumbergs, Renée J. Turne

A temperature-dependent phenology model for Apanteles subandinus Blanchard, parasitoid of Phthorimaea operculella Zeller and Symmetrischema tangolias (Gyen)

The potato tuber moth (Phthorimaea operculella Zeller) is a major invasive pest of potato (Solanum tuberosum L.) worldwide. Classical biological control using parasitoids had been of primary interest during the last decades to control this pest. More than twenty parasitoid species have been reported parasitizing P. operculella. Apanteles subandinus Blanchard had been successfully used in different countries. Determination of the parasitoid's temperature-dependent development is crucial for better predicting the potential of the parasitoid to establish in a new region and to control the target pest. Therefore, the effect of temperature on the development and reproduction of A. subandinus was studied at five constant temperatures ranging from 11-30 degrees C in its main host P. operculella. The Insect Life Cycle Modeling (ILCYM) software was used to fit nonlinear equations to collected life table data and to establish an overall phenology model to simulate life table parameters based on temperature. The parasitoid completed its life cycle at constant temperatures from 15 to 30 degrees C. Temperature of 11 degrees C was lethal to pupae, and at 35 degrees C no larvae development was possible. The theoretical lower threshold temperatures for the development of egg-larvae and pupae were 10.3 degrees C and 11.8 degrees C respectively. The model predicted limits for survival at around 12 degrees C and 33 degrees C. The lowest senescence rate was observed within the temperature range of 15-25 degrees C. Oviposition time decreased significantly with increasing temperature from 12.2 days (15 degrees C) to 1.8 days (30 degrees C). The highest fertility was predicted at 27 degrees C. Maximum population growth is expected around 26.78 degrees C with a finite rate of increase, lambda of 1.0445, which corresponds to a population doubling time of 15.9 days. The highest values for gross reproduction rate (GRR) and net reproduction rate (R0) were found between 24 and 25 degrees C, and the shortest mean generation time (T) was observed at 30 degrees C (23.48 d). The use of the phenology model in the context of classical biological control of P. operculella is discussed